nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinorelbine—Vinca Alkaloids—Vincristine—kidney cancer	0.145	0.5	CiPCiCtD
Vinorelbine—Vinca Alkaloids—Vinblastine—kidney cancer	0.145	0.5	CiPCiCtD
Vinorelbine—lung cancer—kidney cancer	0.115	1	CtDrD
Vinorelbine—Vincristine—kidney cancer	0.111	0.5	CrCtD
Vinorelbine—Vinblastine—kidney cancer	0.111	0.5	CrCtD
Vinorelbine—Vindesine—Vincristine—kidney cancer	0.0263	0.189	CrCrCtD
Vinorelbine—Vinblastine—Vincristine—kidney cancer	0.0263	0.189	CrCrCtD
Vinorelbine—Vindesine—Vinblastine—kidney cancer	0.0263	0.189	CrCrCtD
Vinorelbine—Vincristine—Vinblastine—kidney cancer	0.0263	0.189	CrCrCtD
Vinorelbine—ABCB1—kidney cancer	0.0224	1	CbGaD
Vinorelbine—Voacamine—Vinblastine—kidney cancer	0.0168	0.121	CrCrCtD
Vinorelbine—Voacamine—Vincristine—kidney cancer	0.0168	0.121	CrCrCtD
Vinorelbine—TUBB4A—Paclitaxel—kidney cancer	0.00647	0.0399	CbGbCtD
Vinorelbine—TUBB2B—Paclitaxel—kidney cancer	0.00647	0.0399	CbGbCtD
Vinorelbine—TUBB3—Paclitaxel—kidney cancer	0.00647	0.0399	CbGbCtD
Vinorelbine—TUBB2A—Paclitaxel—kidney cancer	0.00647	0.0399	CbGbCtD
Vinorelbine—TUBB6—Paclitaxel—kidney cancer	0.00647	0.0399	CbGbCtD
Vinorelbine—TUBB8—Paclitaxel—kidney cancer	0.00647	0.0399	CbGbCtD
Vinorelbine—TUBB2B—Vinblastine—kidney cancer	0.00567	0.035	CbGbCtD
Vinorelbine—TUBB6—Vinblastine—kidney cancer	0.00567	0.035	CbGbCtD
Vinorelbine—TUBB2A—Vinblastine—kidney cancer	0.00567	0.035	CbGbCtD
Vinorelbine—TUBB4A—Vinblastine—kidney cancer	0.00567	0.035	CbGbCtD
Vinorelbine—TUBB3—Vinblastine—kidney cancer	0.00567	0.035	CbGbCtD
Vinorelbine—TUBB8—Vinblastine—kidney cancer	0.00567	0.035	CbGbCtD
Vinorelbine—TUBB2A—Vincristine—kidney cancer	0.00558	0.0344	CbGbCtD
Vinorelbine—TUBB4A—Vincristine—kidney cancer	0.00558	0.0344	CbGbCtD
Vinorelbine—TUBB2B—Vincristine—kidney cancer	0.00558	0.0344	CbGbCtD
Vinorelbine—TUBB3—Vincristine—kidney cancer	0.00558	0.0344	CbGbCtD
Vinorelbine—TUBB6—Vincristine—kidney cancer	0.00558	0.0344	CbGbCtD
Vinorelbine—TUBB8—Vincristine—kidney cancer	0.00558	0.0344	CbGbCtD
Vinorelbine—TUBB4B—Paclitaxel—kidney cancer	0.00541	0.0334	CbGbCtD
Vinorelbine—TUBB—Paclitaxel—kidney cancer	0.00541	0.0334	CbGbCtD
Vinorelbine—TUBB1—Paclitaxel—kidney cancer	0.00541	0.0334	CbGbCtD
Vinorelbine—TUBB4B—Vinblastine—kidney cancer	0.00475	0.0293	CbGbCtD
Vinorelbine—TUBB1—Vinblastine—kidney cancer	0.00475	0.0293	CbGbCtD
Vinorelbine—TUBB—Vinblastine—kidney cancer	0.00475	0.0293	CbGbCtD
Vinorelbine—TUBB4B—Vincristine—kidney cancer	0.00467	0.0288	CbGbCtD
Vinorelbine—TUBB—Vincristine—kidney cancer	0.00467	0.0288	CbGbCtD
Vinorelbine—TUBB1—Vincristine—kidney cancer	0.00467	0.0288	CbGbCtD
Vinorelbine—ABCB1—Temsirolimus—kidney cancer	0.00112	0.00693	CbGbCtD
Vinorelbine—CYP2D6—Temsirolimus—kidney cancer	0.00106	0.00653	CbGbCtD
Vinorelbine—CYP3A4—Everolimus—kidney cancer	0.000995	0.00614	CbGbCtD
Vinorelbine—CYP3A4—Temsirolimus—kidney cancer	0.000672	0.00415	CbGbCtD
Vinorelbine—ABCB1—Pazopanib—kidney cancer	0.00059	0.00364	CbGbCtD
Vinorelbine—CYP2D6—Pazopanib—kidney cancer	0.000556	0.00343	CbGbCtD
Vinorelbine—ABCB1—Dactinomycin—kidney cancer	0.000539	0.00333	CbGbCtD
Vinorelbine—ABCB1—Gemcitabine—kidney cancer	0.000426	0.00263	CbGbCtD
Vinorelbine—ABCB1—Erlotinib—kidney cancer	0.000421	0.0026	CbGbCtD
Vinorelbine—CYP2D6—Erlotinib—kidney cancer	0.000396	0.00245	CbGbCtD
Vinorelbine—ABCB1—Paclitaxel—kidney cancer	0.000385	0.00238	CbGbCtD
Vinorelbine—CYP3A4—Pazopanib—kidney cancer	0.000353	0.00218	CbGbCtD
Vinorelbine—ABCB1—Sorafenib—kidney cancer	0.000342	0.00211	CbGbCtD
Vinorelbine—ABCB1—Vinblastine—kidney cancer	0.000338	0.00208	CbGbCtD
Vinorelbine—ABCB1—Vincristine—kidney cancer	0.000332	0.00205	CbGbCtD
Vinorelbine—CYP2D6—Sorafenib—kidney cancer	0.000322	0.00199	CbGbCtD
Vinorelbine—CYP2D6—Vinblastine—kidney cancer	0.000318	0.00196	CbGbCtD
Vinorelbine—Vinblastine—JUN—kidney cancer	0.000289	0.599	CrCbGaD
Vinorelbine—ABCB1—Sunitinib—kidney cancer	0.000277	0.00171	CbGbCtD
Vinorelbine—CYP3A4—urine—kidney cancer	0.000262	0.0475	CbGeAlD
Vinorelbine—CYP2D6—urine—kidney cancer	0.000258	0.0467	CbGeAlD
Vinorelbine—CYP3A4—Erlotinib—kidney cancer	0.000252	0.00156	CbGbCtD
Vinorelbine—TUBB6—Zalcitabine—Gemcitabine—kidney cancer	0.000231	0.582	CbGdCrCtD
Vinorelbine—CYP3A4—Paclitaxel—kidney cancer	0.000231	0.00142	CbGbCtD
Vinorelbine—TUBB2B—nephron tubule—kidney cancer	0.000213	0.0385	CbGeAlD
Vinorelbine—ABCB1—Doxorubicin—kidney cancer	0.000208	0.00128	CbGbCtD
Vinorelbine—CYP3A4—Sorafenib—kidney cancer	0.000205	0.00127	CbGbCtD
Vinorelbine—CYP3A4—Vinblastine—kidney cancer	0.000202	0.00125	CbGbCtD
Vinorelbine—TUBB—nephron tubule—kidney cancer	0.000201	0.0365	CbGeAlD
Vinorelbine—TUBB2A—nephron tubule—kidney cancer	0.0002	0.0363	CbGeAlD
Vinorelbine—TUBB4A—renal system—kidney cancer	0.0002	0.0362	CbGeAlD
Vinorelbine—CYP3A4—Vincristine—kidney cancer	0.000199	0.00123	CbGbCtD
Vinorelbine—TUBB6—nephron tubule—kidney cancer	0.000198	0.0358	CbGeAlD
Vinorelbine—CYP2D6—Doxorubicin—kidney cancer	0.000196	0.00121	CbGbCtD
Vinorelbine—TUBB4A—kidney—kidney cancer	0.000194	0.035	CbGeAlD
Vinorelbine—TUBB2B—renal system—kidney cancer	0.000193	0.035	CbGeAlD
Vinorelbine—TUBB2B—cortex of kidney—kidney cancer	0.000182	0.033	CbGeAlD
Vinorelbine—TUBB6—renal system—kidney cancer	0.00018	0.0325	CbGeAlD
Vinorelbine—TUBB4A—gonad—kidney cancer	0.000179	0.0325	CbGeAlD
Vinorelbine—TUBB6—kidney—kidney cancer	0.000174	0.0314	CbGeAlD
Vinorelbine—TUBB2B—gonad—kidney cancer	0.000173	0.0314	CbGeAlD
Vinorelbine—TUBB2B—cardiac atrium—kidney cancer	0.000173	0.0314	CbGeAlD
Vinorelbine—TUBB—cortex of kidney—kidney cancer	0.000172	0.0312	CbGeAlD
Vinorelbine—TUBB4B—nephron tubule—kidney cancer	0.000172	0.0311	CbGeAlD
Vinorelbine—TUBB2A—cortex of kidney—kidney cancer	0.000171	0.0311	CbGeAlD
Vinorelbine—TUBB6—cortex of kidney—kidney cancer	0.000169	0.0306	CbGeAlD
Vinorelbine—CYP3A4—Sunitinib—kidney cancer	0.000166	0.00102	CbGbCtD
Vinorelbine—TUBB—cardiac atrium—kidney cancer	0.000164	0.0297	CbGeAlD
Vinorelbine—TUBB2A—cardiac atrium—kidney cancer	0.000163	0.0295	CbGeAlD
Vinorelbine—TUBB6—gonad—kidney cancer	0.000161	0.0292	CbGeAlD
Vinorelbine—TUBB6—cardiac atrium—kidney cancer	0.000161	0.0291	CbGeAlD
Vinorelbine—TUBB4B—renal system—kidney cancer	0.000156	0.0283	CbGeAlD
Vinorelbine—TUBB4B—kidney—kidney cancer	0.000151	0.0273	CbGeAlD
Vinorelbine—TUBB4B—cortex of kidney—kidney cancer	0.000147	0.0266	CbGeAlD
Vinorelbine—TUBB4B—gonad—kidney cancer	0.00014	0.0254	CbGeAlD
Vinorelbine—TUBB4B—cardiac atrium—kidney cancer	0.00014	0.0253	CbGeAlD
Vinorelbine—CYP3A4—Doxorubicin—kidney cancer	0.000124	0.000768	CbGbCtD
Vinorelbine—TUBB—Azacitidine—Gemcitabine—kidney cancer	0.000118	0.296	CbGdCrCtD
Vinorelbine—Voacamine—ABCB1—kidney cancer	0.000114	0.235	CrCbGaD
Vinorelbine—CYP3A4—renal system—kidney cancer	6.41e-05	0.0116	CbGeAlD
Vinorelbine—CYP2D6—renal system—kidney cancer	6.31e-05	0.0114	CbGeAlD
Vinorelbine—CYP3A4—kidney—kidney cancer	6.2e-05	0.0112	CbGeAlD
Vinorelbine—CYP2D6—kidney—kidney cancer	6.1e-05	0.0111	CbGeAlD
Vinorelbine—ABCB1—nephron tubule—kidney cancer	4.99e-05	0.00905	CbGeAlD
Vinorelbine—TUBB6—Azacitidine—Gemcitabine—kidney cancer	4.86e-05	0.122	CbGdCrCtD
Vinorelbine—ABCB1—renal system—kidney cancer	4.54e-05	0.00822	CbGeAlD
Vinorelbine—ABCB1—kidney—kidney cancer	4.39e-05	0.00795	CbGeAlD
Vinorelbine—ABCB1—cortex of kidney—kidney cancer	4.28e-05	0.00774	CbGeAlD
Vinorelbine—ABCB1—gonad—kidney cancer	4.07e-05	0.00737	CbGeAlD
Vinorelbine—Vinblastine—ABCB1—kidney cancer	4.06e-05	0.0839	CrCbGaD
Vinorelbine—Vincristine—ABCB1—kidney cancer	3.99e-05	0.0825	CrCbGaD
Vinorelbine—Vomiting—Everolimus—kidney cancer	1.28e-05	0.000362	CcSEcCtD
Vinorelbine—Anaemia—Paclitaxel—kidney cancer	1.28e-05	0.000361	CcSEcCtD
Vinorelbine—Paraesthesia—Vincristine—kidney cancer	1.28e-05	0.000361	CcSEcCtD
Vinorelbine—Dermatitis bullous—Doxorubicin—kidney cancer	1.27e-05	0.000359	CcSEcCtD
Vinorelbine—Rash—Everolimus—kidney cancer	1.27e-05	0.000359	CcSEcCtD
Vinorelbine—Dermatitis—Everolimus—kidney cancer	1.27e-05	0.000358	CcSEcCtD
Vinorelbine—Headache—Vinblastine—kidney cancer	1.27e-05	0.000358	CcSEcCtD
Vinorelbine—Angioedema—Paclitaxel—kidney cancer	1.26e-05	0.000357	CcSEcCtD
Vinorelbine—Headache—Everolimus—kidney cancer	1.26e-05	0.000356	CcSEcCtD
Vinorelbine—Hypotension—Gemcitabine—kidney cancer	1.26e-05	0.000356	CcSEcCtD
Vinorelbine—Abdominal pain—Dactinomycin—kidney cancer	1.26e-05	0.000355	CcSEcCtD
Vinorelbine—Body temperature increased—Dactinomycin—kidney cancer	1.26e-05	0.000355	CcSEcCtD
Vinorelbine—Asthenia—Sorafenib—kidney cancer	1.25e-05	0.000354	CcSEcCtD
Vinorelbine—Malaise—Paclitaxel—kidney cancer	1.25e-05	0.000353	CcSEcCtD
Vinorelbine—Cardiac failure—Doxorubicin—kidney cancer	1.25e-05	0.000352	CcSEcCtD
Vinorelbine—Vertigo—Paclitaxel—kidney cancer	1.24e-05	0.000351	CcSEcCtD
Vinorelbine—Lethargy—Doxorubicin—kidney cancer	1.24e-05	0.00035	CcSEcCtD
Vinorelbine—Cerebrovascular accident—Doxorubicin—kidney cancer	1.24e-05	0.00035	CcSEcCtD
Vinorelbine—Leukopenia—Paclitaxel—kidney cancer	1.24e-05	0.00035	CcSEcCtD
Vinorelbine—Hypersensitivity—Sunitinib—kidney cancer	1.24e-05	0.00035	CcSEcCtD
Vinorelbine—Decreased appetite—Vincristine—kidney cancer	1.24e-05	0.000349	CcSEcCtD
Vinorelbine—Pruritus—Sorafenib—kidney cancer	1.24e-05	0.000349	CcSEcCtD
Vinorelbine—Vomiting—Erlotinib—kidney cancer	1.24e-05	0.000349	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Gemcitabine—kidney cancer	1.23e-05	0.000347	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Vincristine—kidney cancer	1.23e-05	0.000347	CcSEcCtD
Vinorelbine—Fatigue—Vincristine—kidney cancer	1.23e-05	0.000346	CcSEcCtD
Vinorelbine—Rash—Erlotinib—kidney cancer	1.22e-05	0.000346	CcSEcCtD
Vinorelbine—Dermatitis—Erlotinib—kidney cancer	1.22e-05	0.000346	CcSEcCtD
Vinorelbine—Palpitations—Paclitaxel—kidney cancer	1.22e-05	0.000346	CcSEcCtD
Vinorelbine—Hyponatraemia—Doxorubicin—kidney cancer	1.22e-05	0.000345	CcSEcCtD
Vinorelbine—Headache—Erlotinib—kidney cancer	1.22e-05	0.000344	CcSEcCtD
Vinorelbine—Pain—Vincristine—kidney cancer	1.22e-05	0.000344	CcSEcCtD
Vinorelbine—Constipation—Vincristine—kidney cancer	1.22e-05	0.000344	CcSEcCtD
Vinorelbine—Paraesthesia—Gemcitabine—kidney cancer	1.21e-05	0.000342	CcSEcCtD
Vinorelbine—Flushing—Capecitabine—kidney cancer	1.21e-05	0.000342	CcSEcCtD
Vinorelbine—Cardiac disorder—Capecitabine—kidney cancer	1.21e-05	0.000342	CcSEcCtD
Vinorelbine—Cough—Paclitaxel—kidney cancer	1.21e-05	0.000341	CcSEcCtD
Vinorelbine—Asthenia—Sunitinib—kidney cancer	1.21e-05	0.000341	CcSEcCtD
Vinorelbine—Dyspnoea—Gemcitabine—kidney cancer	1.2e-05	0.00034	CcSEcCtD
Vinorelbine—Nausea—Vinblastine—kidney cancer	1.2e-05	0.000339	CcSEcCtD
Vinorelbine—Nausea—Everolimus—kidney cancer	1.2e-05	0.000338	CcSEcCtD
Vinorelbine—Diarrhoea—Sorafenib—kidney cancer	1.2e-05	0.000338	CcSEcCtD
Vinorelbine—Hypertension—Paclitaxel—kidney cancer	1.2e-05	0.000338	CcSEcCtD
Vinorelbine—Pruritus—Sunitinib—kidney cancer	1.19e-05	0.000336	CcSEcCtD
Vinorelbine—Angiopathy—Capecitabine—kidney cancer	1.18e-05	0.000334	CcSEcCtD
Vinorelbine—Immune system disorder—Capecitabine—kidney cancer	1.18e-05	0.000333	CcSEcCtD
Vinorelbine—Chest pain—Paclitaxel—kidney cancer	1.18e-05	0.000333	CcSEcCtD
Vinorelbine—Myalgia—Paclitaxel—kidney cancer	1.18e-05	0.000333	CcSEcCtD
Vinorelbine—Arthralgia—Paclitaxel—kidney cancer	1.18e-05	0.000333	CcSEcCtD
Vinorelbine—Mediastinal disorder—Capecitabine—kidney cancer	1.18e-05	0.000332	CcSEcCtD
Vinorelbine—Decreased appetite—Gemcitabine—kidney cancer	1.17e-05	0.000331	CcSEcCtD
Vinorelbine—Hypersensitivity—Dactinomycin—kidney cancer	1.17e-05	0.000331	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	1.17e-05	0.000331	CcSEcCtD
Vinorelbine—Arrhythmia—Capecitabine—kidney cancer	1.17e-05	0.000329	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Gemcitabine—kidney cancer	1.16e-05	0.000329	CcSEcCtD
Vinorelbine—Discomfort—Paclitaxel—kidney cancer	1.16e-05	0.000329	CcSEcCtD
Vinorelbine—Fatigue—Gemcitabine—kidney cancer	1.16e-05	0.000329	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Vincristine—kidney cancer	1.16e-05	0.000329	CcSEcCtD
Vinorelbine—Dizziness—Sorafenib—kidney cancer	1.16e-05	0.000326	CcSEcCtD
Vinorelbine—Pain—Gemcitabine—kidney cancer	1.15e-05	0.000326	CcSEcCtD
Vinorelbine—Constipation—Gemcitabine—kidney cancer	1.15e-05	0.000326	CcSEcCtD
Vinorelbine—Nausea—Erlotinib—kidney cancer	1.15e-05	0.000326	CcSEcCtD
Vinorelbine—Alopecia—Capecitabine—kidney cancer	1.15e-05	0.000326	CcSEcCtD
Vinorelbine—Diarrhoea—Sunitinib—kidney cancer	1.15e-05	0.000325	CcSEcCtD
Vinorelbine—Asthenia—Dactinomycin—kidney cancer	1.14e-05	0.000323	CcSEcCtD
Vinorelbine—Blood creatinine increased—Doxorubicin—kidney cancer	1.14e-05	0.000322	CcSEcCtD
Vinorelbine—Malnutrition—Capecitabine—kidney cancer	1.14e-05	0.000321	CcSEcCtD
Vinorelbine—Erythema—Capecitabine—kidney cancer	1.14e-05	0.000321	CcSEcCtD
Vinorelbine—Anaphylactic shock—Paclitaxel—kidney cancer	1.13e-05	0.000319	CcSEcCtD
Vinorelbine—Body temperature increased—Vincristine—kidney cancer	1.12e-05	0.000318	CcSEcCtD
Vinorelbine—Abdominal pain—Vincristine—kidney cancer	1.12e-05	0.000318	CcSEcCtD
Vinorelbine—Infection—Paclitaxel—kidney cancer	1.12e-05	0.000317	CcSEcCtD
Vinorelbine—Dizziness—Sunitinib—kidney cancer	1.11e-05	0.000314	CcSEcCtD
Vinorelbine—Feeling abnormal—Gemcitabine—kidney cancer	1.11e-05	0.000314	CcSEcCtD
Vinorelbine—Vomiting—Sorafenib—kidney cancer	1.11e-05	0.000314	CcSEcCtD
Vinorelbine—Nervous system disorder—Paclitaxel—kidney cancer	1.11e-05	0.000313	CcSEcCtD
Vinorelbine—Thrombocytopenia—Paclitaxel—kidney cancer	1.11e-05	0.000312	CcSEcCtD
Vinorelbine—Tachycardia—Paclitaxel—kidney cancer	1.1e-05	0.000311	CcSEcCtD
Vinorelbine—Rash—Sorafenib—kidney cancer	1.1e-05	0.000311	CcSEcCtD
Vinorelbine—Dermatitis—Sorafenib—kidney cancer	1.1e-05	0.000311	CcSEcCtD
Vinorelbine—Back pain—Capecitabine—kidney cancer	1.1e-05	0.00031	CcSEcCtD
Vinorelbine—Skin disorder—Paclitaxel—kidney cancer	1.1e-05	0.00031	CcSEcCtD
Vinorelbine—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	1.09e-05	0.000309	CcSEcCtD
Vinorelbine—Headache—Sorafenib—kidney cancer	1.09e-05	0.000309	CcSEcCtD
Vinorelbine—Diarrhoea—Dactinomycin—kidney cancer	1.09e-05	0.000308	CcSEcCtD
Vinorelbine—Anorexia—Paclitaxel—kidney cancer	1.08e-05	0.000304	CcSEcCtD
Vinorelbine—Muscular weakness—Doxorubicin—kidney cancer	1.07e-05	0.000303	CcSEcCtD
Vinorelbine—Vomiting—Sunitinib—kidney cancer	1.07e-05	0.000302	CcSEcCtD
Vinorelbine—Body temperature increased—Gemcitabine—kidney cancer	1.07e-05	0.000301	CcSEcCtD
Vinorelbine—Rash—Sunitinib—kidney cancer	1.06e-05	0.000299	CcSEcCtD
Vinorelbine—Dermatitis—Sunitinib—kidney cancer	1.06e-05	0.000299	CcSEcCtD
Vinorelbine—Hypotension—Paclitaxel—kidney cancer	1.06e-05	0.000298	CcSEcCtD
Vinorelbine—Ill-defined disorder—Capecitabine—kidney cancer	1.05e-05	0.000298	CcSEcCtD
Vinorelbine—Headache—Sunitinib—kidney cancer	1.05e-05	0.000298	CcSEcCtD
Vinorelbine—Dysphagia—Doxorubicin—kidney cancer	1.05e-05	0.000297	CcSEcCtD
Vinorelbine—Anaemia—Capecitabine—kidney cancer	1.05e-05	0.000297	CcSEcCtD
Vinorelbine—Hypersensitivity—Vincristine—kidney cancer	1.05e-05	0.000296	CcSEcCtD
Vinorelbine—Nausea—Sorafenib—kidney cancer	1.04e-05	0.000293	CcSEcCtD
Vinorelbine—Pancreatitis—Doxorubicin—kidney cancer	1.03e-05	0.000291	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	1.03e-05	0.000291	CcSEcCtD
Vinorelbine—Malaise—Capecitabine—kidney cancer	1.02e-05	0.000289	CcSEcCtD
Vinorelbine—Angina pectoris—Doxorubicin—kidney cancer	1.02e-05	0.000289	CcSEcCtD
Vinorelbine—Vertigo—Capecitabine—kidney cancer	1.02e-05	0.000288	CcSEcCtD
Vinorelbine—Asthenia—Vincristine—kidney cancer	1.02e-05	0.000288	CcSEcCtD
Vinorelbine—Leukopenia—Capecitabine—kidney cancer	1.02e-05	0.000287	CcSEcCtD
Vinorelbine—Paraesthesia—Paclitaxel—kidney cancer	1.01e-05	0.000287	CcSEcCtD
Vinorelbine—Vomiting—Dactinomycin—kidney cancer	1.01e-05	0.000286	CcSEcCtD
Vinorelbine—Dyspnoea—Paclitaxel—kidney cancer	1.01e-05	0.000284	CcSEcCtD
Vinorelbine—Palpitations—Capecitabine—kidney cancer	1e-05	0.000284	CcSEcCtD
Vinorelbine—Rash—Dactinomycin—kidney cancer	1e-05	0.000284	CcSEcCtD
Vinorelbine—Nausea—Sunitinib—kidney cancer	9.99e-06	0.000282	CcSEcCtD
Vinorelbine—Pancytopenia—Doxorubicin—kidney cancer	9.98e-06	0.000282	CcSEcCtD
Vinorelbine—Cough—Capecitabine—kidney cancer	9.91e-06	0.00028	CcSEcCtD
Vinorelbine—Neutropenia—Doxorubicin—kidney cancer	9.83e-06	0.000278	CcSEcCtD
Vinorelbine—Decreased appetite—Paclitaxel—kidney cancer	9.82e-06	0.000277	CcSEcCtD
Vinorelbine—Hypertension—Capecitabine—kidney cancer	9.81e-06	0.000277	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Paclitaxel—kidney cancer	9.75e-06	0.000275	CcSEcCtD
Vinorelbine—Fatigue—Paclitaxel—kidney cancer	9.74e-06	0.000275	CcSEcCtD
Vinorelbine—Diarrhoea—Vincristine—kidney cancer	9.73e-06	0.000275	CcSEcCtD
Vinorelbine—Asthenia—Gemcitabine—kidney cancer	9.68e-06	0.000273	CcSEcCtD
Vinorelbine—Chest pain—Capecitabine—kidney cancer	9.67e-06	0.000273	CcSEcCtD
Vinorelbine—Arthralgia—Capecitabine—kidney cancer	9.67e-06	0.000273	CcSEcCtD
Vinorelbine—Myalgia—Capecitabine—kidney cancer	9.67e-06	0.000273	CcSEcCtD
Vinorelbine—Constipation—Paclitaxel—kidney cancer	9.66e-06	0.000273	CcSEcCtD
Vinorelbine—Pain—Paclitaxel—kidney cancer	9.66e-06	0.000273	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	9.6e-06	0.000271	CcSEcCtD
Vinorelbine—Discomfort—Capecitabine—kidney cancer	9.55e-06	0.00027	CcSEcCtD
Vinorelbine—Pruritus—Gemcitabine—kidney cancer	9.55e-06	0.00027	CcSEcCtD
Vinorelbine—Weight decreased—Doxorubicin—kidney cancer	9.51e-06	0.000269	CcSEcCtD
Vinorelbine—Nausea—Dactinomycin—kidney cancer	9.46e-06	0.000267	CcSEcCtD
Vinorelbine—Pneumonia—Doxorubicin—kidney cancer	9.42e-06	0.000266	CcSEcCtD
Vinorelbine—Dizziness—Vincristine—kidney cancer	9.41e-06	0.000266	CcSEcCtD
Vinorelbine—Infestation—Doxorubicin—kidney cancer	9.37e-06	0.000265	CcSEcCtD
Vinorelbine—Infestation NOS—Doxorubicin—kidney cancer	9.37e-06	0.000265	CcSEcCtD
Vinorelbine—Feeling abnormal—Paclitaxel—kidney cancer	9.31e-06	0.000263	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Paclitaxel—kidney cancer	9.24e-06	0.000261	CcSEcCtD
Vinorelbine—Diarrhoea—Gemcitabine—kidney cancer	9.23e-06	0.000261	CcSEcCtD
Vinorelbine—Infection—Capecitabine—kidney cancer	9.21e-06	0.00026	CcSEcCtD
Vinorelbine—Neuropathy peripheral—Doxorubicin—kidney cancer	9.18e-06	0.000259	CcSEcCtD
Vinorelbine—Stomatitis—Doxorubicin—kidney cancer	9.13e-06	0.000258	CcSEcCtD
Vinorelbine—Nervous system disorder—Capecitabine—kidney cancer	9.09e-06	0.000257	CcSEcCtD
Vinorelbine—Thrombocytopenia—Capecitabine—kidney cancer	9.08e-06	0.000256	CcSEcCtD
Vinorelbine—Tachycardia—Capecitabine—kidney cancer	9.05e-06	0.000256	CcSEcCtD
Vinorelbine—Vomiting—Vincristine—kidney cancer	9.04e-06	0.000255	CcSEcCtD
Vinorelbine—Skin disorder—Capecitabine—kidney cancer	9e-06	0.000254	CcSEcCtD
Vinorelbine—Urticaria—Paclitaxel—kidney cancer	8.97e-06	0.000254	CcSEcCtD
Vinorelbine—Rash—Vincristine—kidney cancer	8.97e-06	0.000253	CcSEcCtD
Vinorelbine—Dermatitis—Vincristine—kidney cancer	8.96e-06	0.000253	CcSEcCtD
Vinorelbine—Body temperature increased—Paclitaxel—kidney cancer	8.93e-06	0.000252	CcSEcCtD
Vinorelbine—Abdominal pain—Paclitaxel—kidney cancer	8.93e-06	0.000252	CcSEcCtD
Vinorelbine—Headache—Vincristine—kidney cancer	8.91e-06	0.000252	CcSEcCtD
Vinorelbine—Hepatobiliary disease—Doxorubicin—kidney cancer	8.86e-06	0.00025	CcSEcCtD
Vinorelbine—Anorexia—Capecitabine—kidney cancer	8.84e-06	0.00025	CcSEcCtD
Vinorelbine—Agranulocytosis—Doxorubicin—kidney cancer	8.74e-06	0.000247	CcSEcCtD
Vinorelbine—Hypotension—Capecitabine—kidney cancer	8.66e-06	0.000245	CcSEcCtD
Vinorelbine—Vomiting—Gemcitabine—kidney cancer	8.58e-06	0.000242	CcSEcCtD
Vinorelbine—Rash—Gemcitabine—kidney cancer	8.51e-06	0.00024	CcSEcCtD
Vinorelbine—Dermatitis—Gemcitabine—kidney cancer	8.5e-06	0.00024	CcSEcCtD
Vinorelbine—Headache—Gemcitabine—kidney cancer	8.45e-06	0.000239	CcSEcCtD
Vinorelbine—Nausea—Vincristine—kidney cancer	8.45e-06	0.000239	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Capecitabine—kidney cancer	8.45e-06	0.000239	CcSEcCtD
Vinorelbine—Hypoaesthesia—Doxorubicin—kidney cancer	8.37e-06	0.000236	CcSEcCtD
Vinorelbine—Paraesthesia—Capecitabine—kidney cancer	8.32e-06	0.000235	CcSEcCtD
Vinorelbine—Hypersensitivity—Paclitaxel—kidney cancer	8.32e-06	0.000235	CcSEcCtD
Vinorelbine—Connective tissue disorder—Doxorubicin—kidney cancer	8.27e-06	0.000233	CcSEcCtD
Vinorelbine—Dyspnoea—Capecitabine—kidney cancer	8.26e-06	0.000233	CcSEcCtD
Vinorelbine—Asthenia—Paclitaxel—kidney cancer	8.11e-06	0.000229	CcSEcCtD
Vinorelbine—Decreased appetite—Capecitabine—kidney cancer	8.06e-06	0.000228	CcSEcCtD
Vinorelbine—Nausea—Gemcitabine—kidney cancer	8.01e-06	0.000226	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Capecitabine—kidney cancer	8e-06	0.000226	CcSEcCtD
Vinorelbine—Fatigue—Capecitabine—kidney cancer	7.99e-06	0.000226	CcSEcCtD
Vinorelbine—Pruritus—Paclitaxel—kidney cancer	7.99e-06	0.000226	CcSEcCtD
Vinorelbine—Constipation—Capecitabine—kidney cancer	7.93e-06	0.000224	CcSEcCtD
Vinorelbine—Pain—Capecitabine—kidney cancer	7.93e-06	0.000224	CcSEcCtD
Vinorelbine—Cardiac disorder—Doxorubicin—kidney cancer	7.81e-06	0.000221	CcSEcCtD
Vinorelbine—Flushing—Doxorubicin—kidney cancer	7.81e-06	0.000221	CcSEcCtD
Vinorelbine—Diarrhoea—Paclitaxel—kidney cancer	7.73e-06	0.000218	CcSEcCtD
Vinorelbine—Feeling abnormal—Capecitabine—kidney cancer	7.64e-06	0.000216	CcSEcCtD
Vinorelbine—Angiopathy—Doxorubicin—kidney cancer	7.63e-06	0.000216	CcSEcCtD
Vinorelbine—Immune system disorder—Doxorubicin—kidney cancer	7.6e-06	0.000215	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Capecitabine—kidney cancer	7.58e-06	0.000214	CcSEcCtD
Vinorelbine—Mediastinal disorder—Doxorubicin—kidney cancer	7.58e-06	0.000214	CcSEcCtD
Vinorelbine—Arrhythmia—Doxorubicin—kidney cancer	7.51e-06	0.000212	CcSEcCtD
Vinorelbine—Dizziness—Paclitaxel—kidney cancer	7.47e-06	0.000211	CcSEcCtD
Vinorelbine—Alopecia—Doxorubicin—kidney cancer	7.43e-06	0.00021	CcSEcCtD
Vinorelbine—Urticaria—Capecitabine—kidney cancer	7.36e-06	0.000208	CcSEcCtD
Vinorelbine—Abdominal pain—Capecitabine—kidney cancer	7.33e-06	0.000207	CcSEcCtD
Vinorelbine—Body temperature increased—Capecitabine—kidney cancer	7.33e-06	0.000207	CcSEcCtD
Vinorelbine—Malnutrition—Doxorubicin—kidney cancer	7.32e-06	0.000207	CcSEcCtD
Vinorelbine—Erythema—Doxorubicin—kidney cancer	7.32e-06	0.000207	CcSEcCtD
Vinorelbine—Vomiting—Paclitaxel—kidney cancer	7.18e-06	0.000203	CcSEcCtD
Vinorelbine—Rash—Paclitaxel—kidney cancer	7.12e-06	0.000201	CcSEcCtD
Vinorelbine—Dermatitis—Paclitaxel—kidney cancer	7.12e-06	0.000201	CcSEcCtD
Vinorelbine—Back pain—Doxorubicin—kidney cancer	7.08e-06	0.0002	CcSEcCtD
Vinorelbine—Headache—Paclitaxel—kidney cancer	7.08e-06	0.0002	CcSEcCtD
Vinorelbine—Hypersensitivity—Capecitabine—kidney cancer	6.83e-06	0.000193	CcSEcCtD
Vinorelbine—Ill-defined disorder—Doxorubicin—kidney cancer	6.79e-06	0.000192	CcSEcCtD
Vinorelbine—Anaemia—Doxorubicin—kidney cancer	6.77e-06	0.000191	CcSEcCtD
Vinorelbine—Nausea—Paclitaxel—kidney cancer	6.71e-06	0.00019	CcSEcCtD
Vinorelbine—TUBB4A—Metabolism of proteins—BCHE—kidney cancer	6.7e-06	0.000996	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—PAX6—kidney cancer	6.69e-06	0.000995	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—RYR1—kidney cancer	6.68e-06	0.000994	CbGpPWpGaD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—SLC5A5—kidney cancer	6.66e-06	0.00099	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—CTSD—kidney cancer	6.66e-06	0.00099	CbGpPWpGaD
Vinorelbine—Asthenia—Capecitabine—kidney cancer	6.65e-06	0.000188	CcSEcCtD
Vinorelbine—Malaise—Doxorubicin—kidney cancer	6.6e-06	0.000187	CcSEcCtD
Vinorelbine—Vertigo—Doxorubicin—kidney cancer	6.58e-06	0.000186	CcSEcCtD
Vinorelbine—Pruritus—Capecitabine—kidney cancer	6.56e-06	0.000185	CcSEcCtD
Vinorelbine—Leukopenia—Doxorubicin—kidney cancer	6.55e-06	0.000185	CcSEcCtD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—ABCB1—kidney cancer	6.53e-06	0.000971	CbGpPWpGaD
Vinorelbine—Palpitations—Doxorubicin—kidney cancer	6.47e-06	0.000183	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle—BIRC5—kidney cancer	6.45e-06	0.000959	CbGpPWpGaD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—SLC2A1—kidney cancer	6.43e-06	0.000957	CbGpPWpGaD
Vinorelbine—Cough—Doxorubicin—kidney cancer	6.39e-06	0.00018	CcSEcCtD
Vinorelbine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	6.35e-06	0.000944	CbGpPWpGaD
Vinorelbine—Diarrhoea—Capecitabine—kidney cancer	6.34e-06	0.000179	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CDKN2B—kidney cancer	6.34e-06	0.000942	CbGpPWpGaD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—ABCB1—kidney cancer	6.33e-06	0.00094	CbGpPWpGaD
Vinorelbine—Hypertension—Doxorubicin—kidney cancer	6.32e-06	0.000179	CcSEcCtD
Vinorelbine—TUBB6—Metabolism of proteins—IGF2—kidney cancer	6.32e-06	0.000939	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—IGF2—kidney cancer	6.32e-06	0.000939	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—BRCA2—kidney cancer	6.25e-06	0.000929	CbGpPWpGaD
Vinorelbine—Arthralgia—Doxorubicin—kidney cancer	6.23e-06	0.000176	CcSEcCtD
Vinorelbine—Myalgia—Doxorubicin—kidney cancer	6.23e-06	0.000176	CcSEcCtD
Vinorelbine—Chest pain—Doxorubicin—kidney cancer	6.23e-06	0.000176	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle—CDKN2B—kidney cancer	6.2e-06	0.000921	CbGpPWpGaD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	6.19e-06	0.000175	CcSEcCtD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—ABCB1—kidney cancer	6.19e-06	0.00092	CbGpPWpGaD
Vinorelbine—Discomfort—Doxorubicin—kidney cancer	6.16e-06	0.000174	CcSEcCtD
Vinorelbine—Dizziness—Capecitabine—kidney cancer	6.13e-06	0.000173	CcSEcCtD
Vinorelbine—TUBB4B—Metabolism of proteins—BCHE—kidney cancer	6.13e-06	0.000911	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—IGF2—kidney cancer	6.1e-06	0.000907	CbGpPWpGaD
Vinorelbine—CYP2D6—Biological oxidations—GSTT1—kidney cancer	6.07e-06	0.000903	CbGpPWpGaD
Vinorelbine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—kidney cancer	5.98e-06	0.00089	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—BIRC5—kidney cancer	5.98e-06	0.000889	CbGpPWpGaD
Vinorelbine—Anaphylactic shock—Doxorubicin—kidney cancer	5.98e-06	0.000169	CcSEcCtD
Vinorelbine—Infection—Doxorubicin—kidney cancer	5.94e-06	0.000168	CcSEcCtD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—ACHE—kidney cancer	5.93e-06	0.000881	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—IGF2—kidney cancer	5.91e-06	0.000879	CbGpPWpGaD
Vinorelbine—Vomiting—Capecitabine—kidney cancer	5.89e-06	0.000166	CcSEcCtD
Vinorelbine—Nervous system disorder—Doxorubicin—kidney cancer	5.86e-06	0.000166	CcSEcCtD
Vinorelbine—Thrombocytopenia—Doxorubicin—kidney cancer	5.85e-06	0.000165	CcSEcCtD
Vinorelbine—Rash—Capecitabine—kidney cancer	5.85e-06	0.000165	CcSEcCtD
Vinorelbine—Dermatitis—Capecitabine—kidney cancer	5.84e-06	0.000165	CcSEcCtD
Vinorelbine—Tachycardia—Doxorubicin—kidney cancer	5.83e-06	0.000165	CcSEcCtD
Vinorelbine—Headache—Capecitabine—kidney cancer	5.81e-06	0.000164	CcSEcCtD
Vinorelbine—Skin disorder—Doxorubicin—kidney cancer	5.8e-06	0.000164	CcSEcCtD
Vinorelbine—TUBB1—Metabolism of proteins—IGF2—kidney cancer	5.78e-06	0.000859	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—BRCA2—kidney cancer	5.72e-06	0.00085	CbGpPWpGaD
Vinorelbine—Anorexia—Doxorubicin—kidney cancer	5.7e-06	0.000161	CcSEcCtD
Vinorelbine—CYP2D6—Biological oxidations—PTGS1—kidney cancer	5.69e-06	0.000846	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CDKN2B—kidney cancer	5.67e-06	0.000843	CbGpPWpGaD
Vinorelbine—Hypotension—Doxorubicin—kidney cancer	5.58e-06	0.000158	CcSEcCtD
Vinorelbine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	5.57e-06	0.000828	CbGpPWpGaD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—ABCB1—kidney cancer	5.55e-06	0.000826	CbGpPWpGaD
Vinorelbine—Nausea—Capecitabine—kidney cancer	5.51e-06	0.000156	CcSEcCtD
Vinorelbine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	5.49e-06	0.000817	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—BIRC5—kidney cancer	5.47e-06	0.000813	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	5.45e-06	0.000809	CbGpPWpGaD
Vinorelbine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	5.44e-06	0.000154	CcSEcCtD
Vinorelbine—Paraesthesia—Doxorubicin—kidney cancer	5.37e-06	0.000152	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle—BIRC5—kidney cancer	5.35e-06	0.000795	CbGpPWpGaD
Vinorelbine—Dyspnoea—Doxorubicin—kidney cancer	5.33e-06	0.00015	CcSEcCtD
Vinorelbine—Decreased appetite—Doxorubicin—kidney cancer	5.19e-06	0.000147	CcSEcCtD
Vinorelbine—TUBB4A—Metabolism of proteins—IGF2—kidney cancer	5.19e-06	0.000771	CbGpPWpGaD
Vinorelbine—Gastrointestinal disorder—Doxorubicin—kidney cancer	5.16e-06	0.000146	CcSEcCtD
Vinorelbine—Fatigue—Doxorubicin—kidney cancer	5.15e-06	0.000146	CcSEcCtD
Vinorelbine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—kidney cancer	5.15e-06	0.000765	CbGpPWpGaD
Vinorelbine—Pain—Doxorubicin—kidney cancer	5.11e-06	0.000144	CcSEcCtD
Vinorelbine—Constipation—Doxorubicin—kidney cancer	5.11e-06	0.000144	CcSEcCtD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—ABCB1—kidney cancer	5.08e-06	0.000755	CbGpPWpGaD
Vinorelbine—Feeling abnormal—Doxorubicin—kidney cancer	4.92e-06	0.000139	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle—BIRC5—kidney cancer	4.89e-06	0.000727	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	4.89e-06	0.000727	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	4.89e-06	0.000727	CbGpPWpGaD
Vinorelbine—Gastrointestinal pain—Doxorubicin—kidney cancer	4.89e-06	0.000138	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CDKN2A—kidney cancer	4.78e-06	0.000711	CbGpPWpGaD
Vinorelbine—Urticaria—Doxorubicin—kidney cancer	4.75e-06	0.000134	CcSEcCtD
Vinorelbine—TUBB4B—Metabolism of proteins—IGF2—kidney cancer	4.75e-06	0.000705	CbGpPWpGaD
Vinorelbine—Abdominal pain—Doxorubicin—kidney cancer	4.72e-06	0.000133	CcSEcCtD
Vinorelbine—Body temperature increased—Doxorubicin—kidney cancer	4.72e-06	0.000133	CcSEcCtD
Vinorelbine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—kidney cancer	4.58e-06	0.000681	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	4.57e-06	0.00068	CbGpPWpGaD
Vinorelbine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	4.51e-06	0.000671	CbGpPWpGaD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—JUN—kidney cancer	4.49e-06	0.000667	CbGpPWpGaD
Vinorelbine—Hypersensitivity—Doxorubicin—kidney cancer	4.4e-06	0.000124	CcSEcCtD
Vinorelbine—Asthenia—Doxorubicin—kidney cancer	4.29e-06	0.000121	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle—CDKN2A—kidney cancer	4.28e-06	0.000636	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CDKN1B—kidney cancer	4.24e-06	0.00063	CbGpPWpGaD
Vinorelbine—Pruritus—Doxorubicin—kidney cancer	4.23e-06	0.000119	CcSEcCtD
Vinorelbine—TUBB6—Metabolism of proteins—POMC—kidney cancer	4.22e-06	0.000627	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—POMC—kidney cancer	4.22e-06	0.000627	CbGpPWpGaD
Vinorelbine—CYP2D6—Biological oxidations—GSTP1—kidney cancer	4.21e-06	0.000626	CbGpPWpGaD
Vinorelbine—CYP2D6—Metapathway biotransformation—GSTP1—kidney cancer	4.15e-06	0.000617	CbGpPWpGaD
Vinorelbine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	4.15e-06	0.000617	CbGpPWpGaD
Vinorelbine—Diarrhoea—Doxorubicin—kidney cancer	4.09e-06	0.000115	CcSEcCtD
Vinorelbine—TUBB3—Metabolism of proteins—POMC—kidney cancer	4.07e-06	0.000605	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CCND1—kidney cancer	4.04e-06	0.000601	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	4.01e-06	0.000597	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—IL2—kidney cancer	4e-06	0.000594	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	3.98e-06	0.000592	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—GSTT1—kidney cancer	3.97e-06	0.00059	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CDKN2A—kidney cancer	3.96e-06	0.000589	CbGpPWpGaD
Vinorelbine—Dizziness—Doxorubicin—kidney cancer	3.95e-06	0.000112	CcSEcCtD
Vinorelbine—TUBB2A—Metabolism of proteins—POMC—kidney cancer	3.94e-06	0.000586	CbGpPWpGaD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—kidney cancer	3.92e-06	0.000583	CbGpPWpGaD
Vinorelbine—CYP2D6—Biological oxidations—GSTM1—kidney cancer	3.87e-06	0.000575	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—POMC—kidney cancer	3.86e-06	0.000573	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—ATP7B—kidney cancer	3.84e-06	0.000571	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—ANXA2—kidney cancer	3.84e-06	0.000571	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	3.84e-06	0.000571	CbGpPWpGaD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—RAF1—kidney cancer	3.83e-06	0.000569	CbGpPWpGaD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—RAF1—kidney cancer	3.83e-06	0.000569	CbGpPWpGaD
Vinorelbine—CYP2D6—Metapathway biotransformation—GSTM1—kidney cancer	3.81e-06	0.000567	CbGpPWpGaD
Vinorelbine—Vomiting—Doxorubicin—kidney cancer	3.8e-06	0.000107	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle—CDKN1B—kidney cancer	3.79e-06	0.000563	CbGpPWpGaD
Vinorelbine—Rash—Doxorubicin—kidney cancer	3.77e-06	0.000106	CcSEcCtD
Vinorelbine—Dermatitis—Doxorubicin—kidney cancer	3.76e-06	0.000106	CcSEcCtD
Vinorelbine—Headache—Doxorubicin—kidney cancer	3.74e-06	0.000106	CcSEcCtD
Vinorelbine—CYP3A4—Biological oxidations—PTGS1—kidney cancer	3.72e-06	0.000553	CbGpPWpGaD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—RAF1—kidney cancer	3.7e-06	0.000549	CbGpPWpGaD
Vinorelbine—CYP2D6—Biological oxidations—CYP1A1—kidney cancer	3.67e-06	0.000545	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CDKN2A—kidney cancer	3.63e-06	0.000539	CbGpPWpGaD
Vinorelbine—CYP2D6—Metapathway biotransformation—CYP1A1—kidney cancer	3.62e-06	0.000538	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—CCND1—kidney cancer	3.61e-06	0.000537	CbGpPWpGaD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—RAF1—kidney cancer	3.58e-06	0.000532	CbGpPWpGaD
Vinorelbine—Nausea—Doxorubicin—kidney cancer	3.55e-06	0.0001	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle—CDKN2A—kidney cancer	3.54e-06	0.000527	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CDKN1B—kidney cancer	3.51e-06	0.000522	CbGpPWpGaD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—RAF1—kidney cancer	3.5e-06	0.00052	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—POMC—kidney cancer	3.46e-06	0.000515	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ACY1—kidney cancer	3.42e-06	0.000509	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—VEGFA—kidney cancer	3.4e-06	0.000505	CbGpPWpGaD
Vinorelbine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	3.36e-06	0.0005	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CCND1—kidney cancer	3.35e-06	0.000498	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—MAPK3—kidney cancer	3.33e-06	0.000495	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—MYC—kidney cancer	3.24e-06	0.000482	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CDKN2A—kidney cancer	3.24e-06	0.000482	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ACY1—kidney cancer	3.23e-06	0.000479	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CDKN1B—kidney cancer	3.21e-06	0.000477	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—MAPK1—kidney cancer	3.17e-06	0.000471	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—POMC—kidney cancer	3.17e-06	0.000471	CbGpPWpGaD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—RAF1—kidney cancer	3.14e-06	0.000467	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CDKN1B—kidney cancer	3.14e-06	0.000467	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CCND1—kidney cancer	3.06e-06	0.000455	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—CTNNB1—kidney cancer	3.01e-06	0.000447	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—CTNNB1—kidney cancer	3.01e-06	0.000447	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CCND1—kidney cancer	2.99e-06	0.000445	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—MAPK3—kidney cancer	2.98e-06	0.000443	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PDHB—kidney cancer	2.91e-06	0.000433	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—CTNNB1—kidney cancer	2.91e-06	0.000432	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—MYC—kidney cancer	2.9e-06	0.000431	CbGpPWpGaD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—RAF1—kidney cancer	2.87e-06	0.000427	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CDKN1B—kidney cancer	2.87e-06	0.000427	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—MAPK1—kidney cancer	2.84e-06	0.000422	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—CTNNB1—kidney cancer	2.82e-06	0.000419	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	2.8e-06	0.000417	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—MAPK3—kidney cancer	2.76e-06	0.000411	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—CTNNB1—kidney cancer	2.75e-06	0.000409	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—GSTP1—kidney cancer	2.75e-06	0.000409	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PDHB—kidney cancer	2.74e-06	0.000408	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CCND1—kidney cancer	2.74e-06	0.000407	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CCBL1—kidney cancer	2.74e-06	0.000407	CbGpPWpGaD
Vinorelbine—CYP2D6—Biological oxidations—POMC—kidney cancer	2.73e-06	0.000406	CbGpPWpGaD
Vinorelbine—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	2.71e-06	0.000403	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—MYC—kidney cancer	2.69e-06	0.000399	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—MAPK1—kidney cancer	2.63e-06	0.000391	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CCBL1—kidney cancer	2.58e-06	0.000383	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—GSTM1—kidney cancer	2.53e-06	0.000376	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—MAPK3—kidney cancer	2.53e-06	0.000375	CbGpPWpGaD
Vinorelbine—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	2.49e-06	0.000371	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—CTNNB1—kidney cancer	2.47e-06	0.000367	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—MAPK3—kidney cancer	2.47e-06	0.000367	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—MYC—kidney cancer	2.46e-06	0.000365	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—MAPK1—kidney cancer	2.4e-06	0.000357	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—MYC—kidney cancer	2.4e-06	0.000357	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	2.4e-06	0.000356	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—TP53—kidney cancer	2.38e-06	0.000354	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PPAT—kidney cancer	2.37e-06	0.000353	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GLIPR1—kidney cancer	2.37e-06	0.000353	CbGpPWpGaD
Vinorelbine—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	2.36e-06	0.000351	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—MAPK1—kidney cancer	2.35e-06	0.000349	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—CTNNB1—kidney cancer	2.26e-06	0.000336	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—MAPK3—kidney cancer	2.26e-06	0.000336	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GLIPR1—kidney cancer	2.24e-06	0.000332	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PPAT—kidney cancer	2.24e-06	0.000332	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—APRT—kidney cancer	2.21e-06	0.000328	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—FH—kidney cancer	2.21e-06	0.000328	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	2.2e-06	0.000327	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—MYC—kidney cancer	2.2e-06	0.000327	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	2.18e-06	0.000323	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—MAPK1—kidney cancer	2.15e-06	0.000319	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	2.13e-06	0.000316	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ACY1—kidney cancer	2.11e-06	0.000313	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—FH—kidney cancer	2.08e-06	0.000309	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—APRT—kidney cancer	2.08e-06	0.000309	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GPC3—kidney cancer	2.07e-06	0.000308	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.02e-06	0.000301	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CA2—kidney cancer	2.02e-06	0.0003	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	2.02e-06	0.0003	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—TP53—kidney cancer	1.97e-06	0.000293	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ALAD—kidney cancer	1.97e-06	0.000292	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.96e-06	0.000291	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GPC3—kidney cancer	1.95e-06	0.00029	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	1.92e-06	0.000286	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ST3GAL2—kidney cancer	1.92e-06	0.000285	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	1.92e-06	0.000285	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	1.9e-06	0.000283	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CA2—kidney cancer	1.9e-06	0.000283	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ALDH1A1—kidney cancer	1.88e-06	0.000279	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	1.86e-06	0.000276	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ALAD—kidney cancer	1.85e-06	0.000275	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ST3GAL2—kidney cancer	1.81e-06	0.000269	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—TP53—kidney cancer	1.8e-06	0.000268	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PGK1—kidney cancer	1.8e-06	0.000267	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—SLC5A3—kidney cancer	1.8e-06	0.000267	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PDHB—kidney cancer	1.79e-06	0.000267	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—POMC—kidney cancer	1.79e-06	0.000266	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ALDH1A1—kidney cancer	1.77e-06	0.000263	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—LDHB—kidney cancer	1.76e-06	0.000262	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—SLC5A3—kidney cancer	1.69e-06	0.000252	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PGK1—kidney cancer	1.69e-06	0.000252	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CCBL1—kidney cancer	1.69e-06	0.000251	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	1.68e-06	0.000249	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—LDHB—kidney cancer	1.66e-06	0.000247	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	1.59e-06	0.000236	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.54e-06	0.000229	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CA9—kidney cancer	1.53e-06	0.000227	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.51e-06	0.000224	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PPAT—kidney cancer	1.46e-06	0.000217	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.46e-06	0.000217	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CA9—kidney cancer	1.44e-06	0.000214	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.42e-06	0.000212	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—APRT—kidney cancer	1.36e-06	0.000202	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—FH—kidney cancer	1.36e-06	0.000202	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.31e-06	0.000195	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CRABP1—kidney cancer	1.3e-06	0.000193	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GPC3—kidney cancer	1.28e-06	0.00019	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	1.27e-06	0.000188	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CA2—kidney cancer	1.24e-06	0.000185	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CRABP1—kidney cancer	1.22e-06	0.000182	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ALAD—kidney cancer	1.21e-06	0.00018	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ITPR2—kidney cancer	1.21e-06	0.00018	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.18e-06	0.000176	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.16e-06	0.000172	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ITPR2—kidney cancer	1.14e-06	0.000169	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.11e-06	0.000165	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PGK1—kidney cancer	1.11e-06	0.000165	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ACHE—kidney cancer	1.1e-06	0.000164	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSTT1—kidney cancer	1.1e-06	0.000164	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—LDHB—kidney cancer	1.09e-06	0.000161	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—SCARB1—kidney cancer	1.04e-06	0.000155	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ACHE—kidney cancer	1.04e-06	0.000154	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSTT1—kidney cancer	1.04e-06	0.000154	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PTGS1—kidney cancer	1.03e-06	0.000154	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PSMD7—kidney cancer	1.01e-06	0.000151	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—SCARB1—kidney cancer	9.83e-07	0.000146	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PTGS1—kidney cancer	9.73e-07	0.000145	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—BCHE—kidney cancer	9.6e-07	0.000143	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PSMD7—kidney cancer	9.54e-07	0.000142	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—SLC5A5—kidney cancer	9.48e-07	0.000141	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CA9—kidney cancer	9.42e-07	0.00014	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—SLC2A1—kidney cancer	9.16e-07	0.000136	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—BCHE—kidney cancer	9.05e-07	0.000134	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—SLC5A5—kidney cancer	8.94e-07	0.000133	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	8.73e-07	0.00013	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—SLC2A1—kidney cancer	8.63e-07	0.000128	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CRABP1—kidney cancer	8.01e-07	0.000119	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSTP1—kidney cancer	7.64e-07	0.000114	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ITPR2—kidney cancer	7.44e-07	0.000111	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSTP1—kidney cancer	7.2e-07	0.000107	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSTM1—kidney cancer	7.02e-07	0.000104	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ABCB1—kidney cancer	6.81e-07	0.000101	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ACHE—kidney cancer	6.79e-07	0.000101	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTT1—kidney cancer	6.79e-07	0.000101	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CYP1A1—kidney cancer	6.65e-07	9.89e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSTM1—kidney cancer	6.61e-07	9.83e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—SCARB1—kidney cancer	6.43e-07	9.55e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PTGS1—kidney cancer	6.36e-07	9.46e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CYP1A1—kidney cancer	6.27e-07	9.32e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PSMD7—kidney cancer	6.24e-07	9.27e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—BCHE—kidney cancer	5.91e-07	8.79e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—SLC5A5—kidney cancer	5.84e-07	8.68e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—SLC2A1—kidney cancer	5.64e-07	8.39e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—POMC—kidney cancer	4.96e-07	7.37e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTP1—kidney cancer	4.71e-07	7e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—POMC—kidney cancer	4.67e-07	6.95e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ABCB1—kidney cancer	4.45e-07	6.62e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTM1—kidney cancer	4.32e-07	6.43e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CYP1A1—kidney cancer	4.1e-07	6.09e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PTGS2—kidney cancer	3.96e-07	5.88e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PTGS2—kidney cancer	3.73e-07	5.54e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PTEN—kidney cancer	3.45e-07	5.13e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PTEN—kidney cancer	3.25e-07	4.83e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—POMC—kidney cancer	3.06e-07	4.54e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PTGS2—kidney cancer	2.44e-07	3.62e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PIK3CA—kidney cancer	2.43e-07	3.62e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PIK3CA—kidney cancer	2.29e-07	3.41e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PTEN—kidney cancer	2.13e-07	3.16e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.5e-07	2.23e-05	CbGpPWpGaD
